FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Thread starter U.S. News
Start date Jun 9, 2025

U.S. News

Guest

Jun 9, 2025

Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Prefix: N/A

Forum: USA News

Start date: Jun 9, 2025

Last reply date: Jun 9, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Jun 9, 2025

Replies: 0

Views: 15

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search